glp 1 discontinuation rates Weight maintenance after of GLP-1 therapies New Truveta study highlights patterns

H., Hwang, J., Keller, R., Koyanagi, A., Jacob, L., Dragioti, E., Smith, L., Correll, C

Patients begin at low introductory doses and gradually increase to therapeutic levels over several weeks

Reduced appetite and cravings Decreased food noise Improved feelings of fullness Better blood sugar regulation Improved insulin sensitivity Significant and sustainable weight loss Reduction of visceral abdominal fat More Than a Quick Fix Many patients describe one of the biggest benefits as finally feeling in control of their eating habits without constant hunger, cravings, or thoughts about food

However, they conclude: It has become increasingly clear that ASD treatment is not one-size-fits-all, and that personalised, multi-modality treatment approaches to help address the total load of stressors are likely required to achieve optimal outcomes